天新药业: 投资者关系管理制度

Core Viewpoint - The document outlines the investor relations management system of Jiangxi Tianxin Pharmaceutical Co., Ltd, emphasizing the importance of effective communication between the company and its investors to enhance corporate governance and protect investor rights [1][2]. Group 1: Objectives and Principles of Investor Relations Management - The objectives of investor relations management include promoting a positive relationship with investors, establishing a stable investor base, fostering a culture of respect for investors, maximizing overall company benefits, and increasing transparency in information disclosure [1][2]. - The basic principles of investor relations management are compliance, equality, proactivity, and honesty [1][2]. Group 2: Communication and Disclosure - The company is required to communicate with investors about its development strategy, legal disclosures, operational information, and other relevant data [3][4]. - Various communication methods include regular reports, annual meetings, one-on-one communications, and online platforms to ensure efficient and broad engagement with investors [3][4]. Group 3: Management Structure and Responsibilities - The board secretary is responsible for investor relations management, supported by the securities department, which organizes and manages investor relations activities [5][6]. - Responsibilities include drafting investor relations policies, handling investor inquiries, and maintaining communication channels [5][6]. Group 4: Compliance and Record-Keeping - The company must adhere to legal disclosure obligations and report any significant information promptly to the Shanghai Stock Exchange [6]. - An investor relations management archive must be established to document activities, including participant details and communication content, with a retention period of no less than three years [6].